Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1

Journal of Ultrasound in Medicine

Volumn 32, Issue 5, 2013, Pages 763-768

  Di Biagio, Antonio ^a   Rosso, Raffaella ^a   Maggi, Paolo ^b   Mazzei, Debora ^c   Bernardini, Claudia ^a   Nulvesu, Loredana ^a   Parisini, Andrea ^a   Nicco, Elena ^a   De Carli, Fabrizio ^d   Rodriguez, Guido ^c   Viscoli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CNR   (Italy)

Author keywords

Antiretroviral therapy; Common carotid intima media thickness; D dimer; Homocysteine; Human immunodeficiency virus; Insulin

Indexed keywords

CORRELATION METHODS; INSULIN; PATHOLOGY; REGRESSION ANALYSIS; VIRUSES;

ANTIRETROVIRALS; COMMON CAROTIDS; D DIMERS; HOMOCYSTEINES; HUMAN IMMUNODEFICIENCY VIRUS;

DISEASES;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CHILD; COMORBIDITY; ECHOGRAPHY; EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; ITALY; MALE; PRESCHOOL CHILD; RISK ASSESSMENT; STATISTICS; VERTICAL TRANSMISSION;

ADOLESCENT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; CAUSALITY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ITALY; MALE; RISK ASSESSMENT;

EID: 84878083208     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.5.763     Document Type: Article

References (23)

1. Oliviero U, Bonadies G, Apuzzi V, et al Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis 2009; 204:586-589.
2. Calza L, Manfredi R, Pocaterra D, Chiodo F. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. J Infect 2008; 57:16-32.
3. de Saint Martin L, Vandhuick O, Guillo P, et al. Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretro-viral therapy (SHIVA study). Atherosclerosis 2006; 185:361-367.
4. Charakida M, Loukogeorgakis SP, Okorie MI, et al. Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy. Antivir Ther 2009; 14:1075-1079.
5. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656.
6. McComsey GA, O'Riordan MA, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007; 21:921-927.
7. Giuliano Ide C, de Freitas SF, de Souza M, Caramelli B. Subclinic atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study. Coron Artery Dis 2008; 19:167-172.
8. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005; 6:3.
9. Ogata T, Yasaka M, Yamagishi M, Seguchi O, Nagatsuka K, Minematsu K. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med 2005; 24:469-474.
10. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation bio-markers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
11. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006): an update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23:75-80.
12. Charakida M, Donald AE, Green H, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 12:103-109.
13. Vigano A, Bedogni G, Cerini C, et al. Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults. Curr HIV Res 2010; 8:411-417.
14. Ross AC, O'Riordan MA, Storer N, Dogra V, McComsey GA. Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children. Atherosclerosis 2010; 211:492-498.
15. Fichtenbaum CJ. Inflammatory markers associated with coronary heart disease in persons with HIV infection. Curr Infect Dis Rep 2011; 13:94-101.
16. Jarvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002; 51:493-498.
17. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hyper-cholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996; 16:984-991.
18. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46:1489-1497.
19. Jitsuiki K, Yamane K, Nakajima M, et al. Association of Chlamydia pneu-moniae infection and carotid intima-media wall thickness in Japanese Americans. Circ J 2006; 70:815-819.
20. Fisher SD, Miller TL, Lipshultz SE. Impact of HIV and highly active anti-retroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis 2006; 185:1-11.
21. De Socio GV, Ricci E, Parruti G, et al. Chronological and biological age in HIV infection. J Infect 2010; 61:428-430.
22. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
23. Rosso R, Parodi A, d'Annunzio G, et al. Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol 2007; 157:655-659.